• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

布地奈德在T =(293.2至313.2)K的1-丙醇+水混合物中的溶解度的实验测量、热力学分析及数学建模

Experimental measurement, thermodynamic analysis, and mathematical modeling for budesonide solubility in 1-propanol + water mixtures at T = (293.2 to 313.2) K.

作者信息

Mohammadian Esmaeil, Dashti Mina, Martinez Fleming, Jouyban Abolghasem

机构信息

Molecular Medicine Research Center, Hormozgan Health Institute, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

Department of Medicinal Chemistry, School of Pharmacy, Hormozgan University of Medical Sciences, Bandar Abbas, Iran.

出版信息

BMC Chem. 2024 Sep 28;18(1):190. doi: 10.1186/s13065-024-01297-x.

DOI:10.1186/s13065-024-01297-x
PMID:39342251
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11439214/
Abstract

Budesonide (BDS) a steroid-based anti-inflammatory drug widely prescribed for various diseases, has a low aqueous solubility. In this study, we investigated cosolvency approach to study the thermodynamic specifications related to the solubility of BDS at the temperature range of 293.2-313.2 K in (1-propanol + water) mixtures applying the shaking flask method. The predictive power of different mathematical models for experimental data in the cosolvency systems was evaluated. For this purpose, the linear and nonlinear mathematical equations such as van't Hoff model (as a linear model), Buchowski-Ksiazczak equation (as a non-linear), CNIBS/R-K and MRS models (as a linear model for solvent composition at an isothermal condition), modified Wilson model (as a non-linear model for isothermal condition), the Jouyban-Acree model (as a model that considers temperature and solvent composition), and Jouyban-Acree-van't Hoff model (as a model with no further input data) were studied. Also, the Williams-Amidon excess Gibbs energy model was investigated. In addition, the related apparent thermodynamics of the BDS dissolution process in the desired temperature such as Gibbs free energy, enthalpy, and entropy, were computed by the corresponding equations. Moreover, based on the inverse Kirkwood-Buff integrals, it is demonstrated that BDS is preferentially solvated by water in water-rich mixtures. The accuracy of the fitness was evaluated with mean relative deviations (MRDs%) for back-calculated molar BDS solubility data. The result showed that the maximum solubility of BDS was obtained at 0.7 mass fraction of 1-propanol at all temperatures. Thermodynamic studies demonstrated that BDS dissolution procedures were obtained as endothermic and entropy-driven in almost all cases. The overall MRDs% values for the back-computed BDS solubility in the aqueous mixture of 1-propanol based on van't Hoff model, Buchowski-Ksiazczak equation, CNIBS/R-K model, modified Wilson model, Jouyban-Acree model, Jouyban-Acree-van't Hoff model, MRS model, and Williams-Amidon excess Gibbs energy model were found 1.93%, 1.80%, 11.68%, 33.32%, 12.30%, 9.24%, 10.70%, and 6.57%, respectively.

摘要

布地奈德(BDS)是一种广泛用于治疗各种疾病的类固醇类抗炎药物,其水溶性较低。在本研究中,我们采用摇瓶法研究了共溶剂法,以考察在293.2 - 313.2 K温度范围内,BDS在(1-丙醇 + 水)混合溶剂中的溶解度相关的热力学特性。评估了共溶剂体系中不同数学模型对实验数据的预测能力。为此,研究了线性和非线性数学方程,如范特霍夫模型(作为线性模型)、布霍夫斯基 - 西亚兹扎克方程(作为非线性模型)、CNIBS/R - K和MRS模型(作为等温条件下溶剂组成的线性模型)、修正威尔逊模型(作为等温条件下的非线性模型)、乔伊班 - 阿克里模型(作为考虑温度和溶剂组成的模型)以及乔伊班 - 阿克里 - 范特霍夫模型(作为无需进一步输入数据的模型)。此外,还研究了威廉姆斯 - 阿米登过量吉布斯自由能模型。另外,通过相应方程计算了BDS在所需温度下溶解过程的相关表观热力学性质,如吉布斯自由能、焓和熵。此外,基于逆柯克伍德 - 布夫积分,证明了在富水混合物中BDS优先被水溶剂化。通过回算的BDS摩尔溶解度数据的平均相对偏差(MRDs%)评估拟合精度。结果表明,在所有温度下,当1-丙醇的质量分数为0.7时,BDS的溶解度最大。热力学研究表明,几乎在所有情况下,BDS的溶解过程都是吸热且由熵驱动的。基于范特霍夫模型、布霍夫斯基 - 西亚兹扎克方程、CNIBS/R - K模型、修正威尔逊模型、乔伊班 - 阿克里模型、乔伊班 - 阿克里 - 范特霍夫模型、MRS模型和威廉姆斯 - 阿米登过量吉布斯自由能模型回算的BDS在1-丙醇水混合溶剂中的总体MRDs%值分别为1.93%、1.80%、11.68%、33.32%、12.30%、9.24%、10.70%和6.57%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/d62c481ee654/13065_2024_1297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/7bad8d9d0a4c/13065_2024_1297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/d1abba084a03/13065_2024_1297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/6b4dcc20b0d8/13065_2024_1297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/b7e04b0b8038/13065_2024_1297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/a8aec56cad1c/13065_2024_1297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/d62c481ee654/13065_2024_1297_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/7bad8d9d0a4c/13065_2024_1297_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/d1abba084a03/13065_2024_1297_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/6b4dcc20b0d8/13065_2024_1297_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/b7e04b0b8038/13065_2024_1297_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/a8aec56cad1c/13065_2024_1297_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c35/11439214/d62c481ee654/13065_2024_1297_Fig6_HTML.jpg

相似文献

1
Experimental measurement, thermodynamic analysis, and mathematical modeling for budesonide solubility in 1-propanol + water mixtures at T = (293.2 to 313.2) K.布地奈德在T =(293.2至313.2)K的1-丙醇+水混合物中的溶解度的实验测量、热力学分析及数学建模
BMC Chem. 2024 Sep 28;18(1):190. doi: 10.1186/s13065-024-01297-x.
2
Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures.苦杏仁苷在乙醇 + 水混合溶剂中的溶解度、溶液热力学及优先溶剂化作用
Pharmaceuticals (Basel). 2020 Nov 16;13(11):395. doi: 10.3390/ph13110395.
3
Solubility and thermodynamics properties of salicylic acid in binary mixtures 1-propanol and propylene glycol/ethylene glycol monomethyl ether at different temperatures.水杨酸在不同温度下于 1-丙醇和丙二醇/乙二醇单甲醚二元混合物中的溶解度和热力学性质。
Ann Pharm Fr. 2024 Nov;82(6):1013-1024. doi: 10.1016/j.pharma.2024.05.004. Epub 2024 May 24.
4
Solubility of codeine phosphate in carbitol + 2-propanol mixture at different temperatures.磷酸可待因在不同温度下于二甘醇+2-丙醇混合物中的溶解度。
Drug Dev Ind Pharm. 2020 Jun;46(6):910-915. doi: 10.1080/03639045.2020.1762203. Epub 2020 May 13.
5
Effect of -Methyl-pyrrolidone (NMP) on the Equilibrium Solubility of Meloxicam in Aqueous Media: Correlation, Dissolution Thermodynamics, and Preferential Solvation.N-甲基吡咯烷酮(NMP)对美洛昔康在水介质中平衡溶解度的影响:相关性、溶解热力学及优先溶剂化作用
ACS Omega. 2022 Oct 14;7(42):37988-38002. doi: 10.1021/acsomega.2c05189. eCollection 2022 Oct 25.
6
Investigation of the solubility and thermodynamics of salicylic acid in 2-propanol and ethylene glycol/propylene glycol binary solvent mixtures at (293.15 to 313.15) K.水杨酸在2-丙醇以及乙二醇/丙二醇二元溶剂混合物中于(293.15至313.15)K温度下的溶解度及热力学研究
BMC Chem. 2024 May 9;18(1):84. doi: 10.1186/s13065-024-01188-1.
7
Solubility determination, mathematical modeling, and thermodynamic analysis of naproxen in binary solvent mixtures of (1-propanol/2-propanol) and ethylene glycol at different temperatures.萘普生在不同温度下于(1-丙醇/2-丙醇)与乙二醇的二元溶剂混合物中的溶解度测定、数学建模及热力学分析
BMC Chem. 2024 Sep 19;18(1):178. doi: 10.1186/s13065-024-01291-3.
8
Dissolution thermodynamics and preferential solvation of genistein in some (ethanol + water) mixtures at different temperatures.染料木黄酮在不同温度下某些(乙醇+水)混合物中的溶解热力学和优先溶剂化作用。
Drug Dev Ind Pharm. 2022 Oct;48(10):575-584. doi: 10.1080/03639045.2022.2141775. Epub 2022 Nov 5.
9
Thermodynamic modelling of solubility and preferential solvation for ribavirin (II) in co-solvent mixtures of (methanol, -propanol, acetonitrile or 1,4-dioxane) + water.利巴韦林(II)在(甲醇、正丙醇、乙腈或1,4 - 二氧六环)+水的混合共溶剂中溶解度和优先溶剂化作用的热力学模型
J Chem Thermodyn. 2017 Dec;115:74-83. doi: 10.1016/j.jct.2017.07.027. Epub 2017 Jul 24.
10
Solubility and thermodynamic study of deferiprone in propylene glycol and ethanol mixture.去铁酮在丙二醇和乙醇混合物中的溶解度及热力学研究
BMC Chem. 2023 Apr 15;17(1):37. doi: 10.1186/s13065-023-00950-1.

本文引用的文献

1
Predicting drug solubility in organic solvents mixtures: A machine-learning approach supported by high-throughput experimentation.预测有机溶剂混合物中的药物溶解度:一种基于高通量实验的机器学习方法。
Int J Pharm. 2024 Jul 20;660:124233. doi: 10.1016/j.ijpharm.2024.124233. Epub 2024 May 18.
2
Oral Fluvoxamine With Inhaled Budesonide for Treatment of Early-Onset COVID-19 : A Randomized Platform Trial.口服氟伏沙明联合布地奈德治疗早期 COVID-19:一项随机平台试验。
Ann Intern Med. 2023 May;176(5):667-675. doi: 10.7326/M22-3305. Epub 2023 Apr 18.
3
Treatment of autoimmune hepatitis: Budesonide does not solve our problems.
自身免疫性肝炎的治疗:布地奈德无法解决我们的问题。
Hepatology. 2023 Apr 1;77(4):1071-1073. doi: 10.1097/HEP.0000000000000183. Epub 2023 Feb 3.
4
Current knowledge of targeted-release budesonide in immunoglobulin A nephropathy: A comprehensive review.目前针对免疫球蛋白 A 肾病中布地奈德靶向释放的认识:全面综述。
Front Immunol. 2023 Jan 4;13:926517. doi: 10.3389/fimmu.2022.926517. eCollection 2022.
5
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial.附加吸入用布地奈德治疗 COVID-19 住院患者的随机临床试验。
Eur Respir J. 2022 Mar 10;59(3). doi: 10.1183/13993003.03036-2021. Print 2022 Mar.
6
Budesonide in the first line treatment of patients with autoimmune hepatitis.布地奈德治疗自身免疫性肝炎患者的一线治疗。
Gastroenterol Hepatol. 2022 Aug-Sep;45(7):561-570. doi: 10.1016/j.gastrohep.2021.11.012. Epub 2021 Dec 16.
7
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.吸入用布地奈德治疗早期 COVID-19(STOIC):一项 2 期、开放标签、随机对照试验。
Lancet Respir Med. 2021 Jul;9(7):763-772. doi: 10.1016/S2213-2600(21)00160-0. Epub 2021 Apr 9.
8
Enhancement strategies for transdermal drug delivery systems: current trends and applications.透皮给药系统的增强策略:当前趋势与应用
Drug Deliv Transl Res. 2022 Apr;12(4):758-791. doi: 10.1007/s13346-021-00909-6. Epub 2021 Jan 20.
9
A Pharmacokinetic Bridging Study to Compare Systemic Exposure to Budesonide between Budesonide Oral Suspension and ENTOCORT EC in Healthy Individuals.一项比较布地奈德混悬液与 ENTOCORT EC 在健康个体中全身暴露的药代动力学桥接研究。
Drugs R D. 2020 Dec;20(4):359-367. doi: 10.1007/s40268-020-00324-1. Epub 2020 Oct 15.
10
Evaluation of 1-Propanol Toxicity in B6C3F1 Mice via Repeated Inhalation over 28 and 90 Days.通过28天和90天重复吸入评估1-丙醇对B6C3F1小鼠的毒性。
J Toxicol. 2020 Sep 24;2020:9172569. doi: 10.1155/2020/9172569. eCollection 2020.